Wisp Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: an oral route if you will not self-inject
Wisp's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked September 2026
$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.
Is Wisp legit?
Yes. Wisp is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.0/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Wisp promo or coupon code?
Wisp publishes the code SUNNY20 (20% off your first order). You enter it at checkout on Wisp's own site. Other codes for Wisp circulate on coupon sites, and we cannot vouch for those.
See how Wisp compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Wisp
Enhance MD
Best for: knowing which pharmacy fills the vial: it names Tru Meds Rx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Wisp at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Wegovy, Zepbound
- Starting price
- $225/mo
- What's included
- Medication · Shipping
- Availability
- 39 states
- FDA status
- No FDA warning letters found
How Wisp scores
Six columns, each one computed from something Wisp has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.6/10$225/month is 22% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
8.2/10Serves 39 of 50 states.
Support10%
4.5/10The price covers the medication and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Wisp
Last checked September 2026- Checked the listed price across 3 dose or plan tiers
- Checked state coverage: 39 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Wisp
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Wisp involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Wisp shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Wisp which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and shipping.
- Lowest ongoing monthly price: semaglutide $225, tirzepatide $99. That leaves out membership fees, first-month rates and insurance copays.
- Wisp serves 39 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Wisp
- Wisp offers email support
- Hours
- 9:30a-6:30p EST M-F
Cancelling Wisp
Taken from the terms Wisp publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Refund policy
- All sales are final
GLP-1 medications Wisp offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.
Wisp's $99 covers the consult and prescription for brand Zepbound; the medication is picked up and paid for at your local pharmacy.
Check the price yourself before you pay
Every figure here was read off Wisp's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $99 a month, 92% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Wisp
Against it
- Semaglutide costs $225 a month, 22% above the $185 median for compounded semaglutide across the sellers we compare
- Serves only 39 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Wisp charges
The standing price at Wisp is $225/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide: $225/month
- Metabolic Support & GLP-1 Boost capsules (adjunct supplement, not a prescription GLP-1): $54/month
- Brand-name tirzepatide: $99/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Wisp's $225 is a premium, and a premium has to buy something. Check what is bundled before you accept it.
HumeCare+ dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What Wisp dispenses
Wisp prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The difference is not cosmetic. The approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Wisp at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Wisp tells you its price before you start the medical questionnaire and the 39 states it serves. We found no FDA warning letters issued to Wisp. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Wisp will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You need insurance to cover the cost. Check whether Wisp bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
Wisp costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Eden is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Wisp's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Wisp
Starting at $225 a month. Check today's price, then start the intake.
Where Wisp is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider Oak.
- If your state is outside the area this one covers, consider DudeMeds.
Compare Wisp head to head
The sellers closest to Wisp on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Wisp review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Wisp's current pricing
Plans start at $225 a month. Whether you qualify is a clinician's decision, made after your intake.